Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q1 FY2027 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 850 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Replimune Group, Inc.
Market Cap
$1.11B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.11B
Operating Margin
-4.13%
TTM Avg
-9.12%
3Y Avg
-15.26%
5Y Avg
-9.90%
Market Cap
$1.11B
Operating Margin
-36.08%
TTM Avg
-28.70%
3Y Avg
-24.53%
5Y Avg
-15.51%
Market Cap
$1.11B
Operating Margin
-19.19%
TTM Avg
-19.19%
3Y Avg
-4.83%
5Y Avg
3.07%
Market Cap
$1.10B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.13B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.13B
Operating Margin
14.18%
TTM Avg
9.30%
3Y Avg
5.28%
5Y Avg
4.02%
Market Cap
$1.09B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.14B
Operating Margin
10.25%
TTM Avg
9.64%
3Y Avg
3.98%
5Y Avg
-5.39%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Replimune Group, Inc. (REPL) | $1.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | -4.13% | -9.12% | -15.26% | -9.90% |
| OPKO Health, Inc. (OPK)vs › | $1.11B | -36.08% | -28.70% | -24.53% | -15.51% |
| STAAR Surgical Company (STAA)vs › | $1.11B | -19.19% | -19.19% | -4.83% | 3.07% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | 0.00% | 0.00% | 0.00% | 0.00% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 0.00% | 0.00% | 0.00% | 0.00% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 14.18% | 9.30% | 5.28% | 4.02% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | 0.00% | 0.00% | 0.00% | 0.00% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | 10.25% | 9.64% | 3.98% | -5.39% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 15.66% | 23.78% | 24.92% | 19.79% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
